Exocrine Pancreatic Insufficiency Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: E172FD0E4917EN
Market Monitor Global

Abstracts

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.

This report contains market size and forecasts of Exocrine Pancreatic Insufficiency in Global, including the following market information:

Global Exocrine Pancreatic Insufficiency Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Exocrine Pancreatic Insufficiency market was valued at 2073.7 million in 2021 and is projected to reach US$ 2682.2 million by 2028, at a CAGR of 3.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Exocrine Pancreatic Insufficiency include Axcan Pharma, Aptalis Pharma, Eli Lilly, Cilian, Nordmark Arzneimittel and Laboratoires Mayoly Spindler, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Exocrine Pancreatic Insufficiency companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Exocrine Pancreatic Insufficiency Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Exocrine Pancreatic Insufficiency Market Segment Percentages, by Type, 2021 (%)

• Therapeutics
• Diagnostics

Global Exocrine Pancreatic Insufficiency Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Exocrine Pancreatic Insufficiency Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Exocrine Pancreatic Insufficiency Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Exocrine Pancreatic Insufficiency Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Exocrine Pancreatic Insufficiency revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Exocrine Pancreatic Insufficiency revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Axcan Pharma
• Aptalis Pharma
• Eli Lilly
• Cilian
• Nordmark Arzneimittel
• Laboratoires Mayoly Spindler

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Exocrine Pancreatic Insufficiency Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Exocrine Pancreatic Insufficiency Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY OVERALL MARKET SIZE

2.1 Global Exocrine Pancreatic Insufficiency Market Size: 2021 VS 2028
2.2 Global Exocrine Pancreatic Insufficiency Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Exocrine Pancreatic Insufficiency Players in Global Market
3.2 Top Global Exocrine Pancreatic Insufficiency Companies Ranked by Revenue
3.3 Global Exocrine Pancreatic Insufficiency Revenue by Companies
3.4 Top 3 and Top 5 Exocrine Pancreatic Insufficiency Companies in Global Market, by Revenue in 2021
3.5 Global Companies Exocrine Pancreatic Insufficiency Product Type
3.6 Tier 1, Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Players in Global Market
  3.6.1 List of Global Tier 1 Exocrine Pancreatic Insufficiency Companies
  3.6.2 List of Global Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Exocrine Pancreatic Insufficiency Market Size Markets, 2021 & 2028
  4.1.2 Therapeutics
  4.1.3 Diagnostics
4.2 By Type - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
  4.2.1 By Type - Global Exocrine Pancreatic Insufficiency Revenue, 2017-2022
  4.2.2 By Type - Global Exocrine Pancreatic Insufficiency Revenue, 2023-2028
  4.2.3 By Type - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Exocrine Pancreatic Insufficiency Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
  5.2.1 By Application - Global Exocrine Pancreatic Insufficiency Revenue, 2017-2022
  5.2.2 By Application - Global Exocrine Pancreatic Insufficiency Revenue, 2023-2028
  5.2.3 By Application - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Exocrine Pancreatic Insufficiency Market Size, 2021 & 2028
6.2 By Region - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
  6.2.1 By Region - Global Exocrine Pancreatic Insufficiency Revenue, 2017-2022
  6.2.2 By Region - Global Exocrine Pancreatic Insufficiency Revenue, 2023-2028
  6.2.3 By Region - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Exocrine Pancreatic Insufficiency Revenue, 2017-2028
  6.3.2 US Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.3.3 Canada Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.3.4 Mexico Exocrine Pancreatic Insufficiency Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Exocrine Pancreatic Insufficiency Revenue, 2017-2028
  6.4.2 Germany Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.3 France Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.4 U.K. Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.5 Italy Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.6 Russia Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.7 Nordic Countries Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.4.8 Benelux Exocrine Pancreatic Insufficiency Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Exocrine Pancreatic Insufficiency Revenue, 2017-2028
  6.5.2 China Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.5.3 Japan Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.5.4 South Korea Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.5.5 Southeast Asia Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.5.6 India Exocrine Pancreatic Insufficiency Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Exocrine Pancreatic Insufficiency Revenue, 2017-2028
  6.6.2 Brazil Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.6.3 Argentina Exocrine Pancreatic Insufficiency Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Exocrine Pancreatic Insufficiency Revenue, 2017-2028
  6.7.2 Turkey Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.7.3 Israel Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.7.4 Saudi Arabia Exocrine Pancreatic Insufficiency Market Size, 2017-2028
  6.7.5 UAE Exocrine Pancreatic Insufficiency Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Axcan Pharma
  7.1.1 Axcan Pharma Corporate Summary
  7.1.2 Axcan Pharma Business Overview
  7.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Major Product Offerings
  7.1.4 Axcan Pharma Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.1.5 Axcan Pharma Key News
7.2 Aptalis Pharma
  7.2.1 Aptalis Pharma Corporate Summary
  7.2.2 Aptalis Pharma Business Overview
  7.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Major Product Offerings
  7.2.4 Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.2.5 Aptalis Pharma Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Major Product Offerings
  7.3.4 Eli Lilly Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Cilian
  7.4.1 Cilian Corporate Summary
  7.4.2 Cilian Business Overview
  7.4.3 Cilian Exocrine Pancreatic Insufficiency Major Product Offerings
  7.4.4 Cilian Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.4.5 Cilian Key News
7.5 Nordmark Arzneimittel
  7.5.1 Nordmark Arzneimittel Corporate Summary
  7.5.2 Nordmark Arzneimittel Business Overview
  7.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Major Product Offerings
  7.5.4 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.5.5 Nordmark Arzneimittel Key News
7.6 Laboratoires Mayoly Spindler
  7.6.1 Laboratoires Mayoly Spindler Corporate Summary
  7.6.2 Laboratoires Mayoly Spindler Business Overview
  7.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Major Product Offerings
  7.6.4 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue in Global Market (2017-2022)
  7.6.5 Laboratoires Mayoly Spindler Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Exocrine Pancreatic Insufficiency Market Opportunities & Trends in Global Market
Table 2. Exocrine Pancreatic Insufficiency Market Drivers in Global Market
Table 3. Exocrine Pancreatic Insufficiency Market Restraints in Global Market
Table 4. Key Players of Exocrine Pancreatic Insufficiency in Global Market
Table 5. Top Exocrine Pancreatic Insufficiency Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Exocrine Pancreatic Insufficiency Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Exocrine Pancreatic Insufficiency Revenue Share by Companies, 2017-2022
Table 8. Global Companies Exocrine Pancreatic Insufficiency Product Type
Table 9. List of Global Tier 1 Exocrine Pancreatic Insufficiency Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Exocrine Pancreatic Insufficiency Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Exocrine Pancreatic Insufficiency Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Exocrine Pancreatic Insufficiency Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Exocrine Pancreatic Insufficiency Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Exocrine Pancreatic Insufficiency Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Exocrine Pancreatic Insufficiency Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2023-2028
Table 30. Axcan Pharma Corporate Summary
Table 31. Axcan Pharma Exocrine Pancreatic Insufficiency Product Offerings
Table 32. Axcan Pharma Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)
Table 33. Aptalis Pharma Corporate Summary
Table 34. Aptalis Pharma Exocrine Pancreatic Insufficiency Product Offerings
Table 35. Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Exocrine Pancreatic Insufficiency Product Offerings
Table 38. Eli Lilly Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)
Table 39. Cilian Corporate Summary
Table 40. Cilian Exocrine Pancreatic Insufficiency Product Offerings
Table 41. Cilian Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)
Table 42. Nordmark Arzneimittel Corporate Summary
Table 43. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Product Offerings
Table 44. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)
Table 45. Laboratoires Mayoly Spindler Corporate Summary
Table 46. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Product Offerings
Table 47. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Exocrine Pancreatic Insufficiency Segment by Type in 2021
Figure 2. Exocrine Pancreatic Insufficiency Segment by Application in 2021
Figure 3. Global Exocrine Pancreatic Insufficiency Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Exocrine Pancreatic Insufficiency Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Exocrine Pancreatic Insufficiency Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Exocrine Pancreatic Insufficiency Revenue in 2021
Figure 8. By Type - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 9. By Application - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 10. By Region - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 11. By Country - North America Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 12. US Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 16. Germany Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 17. France Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 24. China Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 28. India Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 30. Brazil Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Exocrine Pancreatic Insufficiency Revenue Market Share, 2017-2028
Figure 33. Turkey Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Exocrine Pancreatic Insufficiency Revenue, (US$, Mn), 2017-2028
Figure 37. Axcan Pharma Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cilian Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue Year Over Year Growth (US$, Mn) & (2017-2022)